Nutrien (NTR) — Stock Analysis 2026 [4.2]

Analysis as of 25 August 2026. A point-in-time snapshot, not an evergreen guide. Fundamentals come from Nutrien’s 2025 Annual Information Form (year ended 31 December 2025) and its full-year 2025 results released 10 February 2026. Market data is as of the NYSE close on 24 August 2026 ($75.82). Rating: ★★★★, Solid — Fairly valued (wide band) → priced about right: a best-in-class franchise trading close to fair value; the edge is a catalyst. Price deck: the model’s swing input is Nutrien’s own realised potash net selling price (a mine-gate netback, not the delivered retail price), on a US$50/t grid — base US$250/t (2025 realised ~US$252/t, held on the grid), bear US$200/t, deep bear US$150/t (the reversion case), bull US$300/t, deep bull US$350/t; a group target EV/EBITDA of 7.75× anchors the relative work. All figures are US dollars — Nutrien reports in USD. Refreshed on each annual report and on material events. For information only, prepared with AI assistance — see the disclaimer at the end.

Nutrien is the largest crop-nutrient company in the world and, unusually, its own biggest customer’s supplier twice over: it mines about a fifth of the planet’s potash from six Saskatchewan mines and then sells crop inputs to farmers through the largest agricultural-retail network in North America. It trades at roughly 16× trailing earnings, 7.9× EBITDA and a 2.9% dividend yield — a valuation that reflects a mature, cyclical, well-run business the market has already worked out. The thesis in one line: a genuinely best-in-class, long-life potash franchise wrapped inside a diversified fertilizer-and-retail major, priced almost exactly at the sum of its parts, so the return depends less on the discount closing than on the potash cycle and on management finishing its simplification. Why look now: 2025 was a recovery year — adjusted EBITDA back to $6.0 billion, cash returns up 30% — and management is actively pruning the portfolio, with Phosphate and the Trinidad nitrogen assets under review and the Profertil and Sinofert stakes already sold. To screen Nutrien against every listed fertilizer and mining name on production, reserves, cost and value, go to Metal Pilot.

1. Snapshot & thesis

Nutrien Ltd. (TSX & NYSE: NTR) is a diversified crop-nutrient major headquartered in Saskatoon, Saskatchewan, operating across North America, South America and Australia. Its four segments are Potash (six mines in Saskatchewan), Nitrogen (nine ammonia complexes across North America and, until October 2025, Trinidad), Phosphate (two US mines, now under strategic review) and Retail — Nutrien Ag Solutions, more than 1,800 farm-input locations with over 4,200 crop consultants. By archetype it is a diversified major: no single segment clears half of enterprise value, so the full nine-dimension rubric applies (Section 9) and the valuation runs sum-of-the-parts (Section 7). (Potash production and reserves are stated in Mt = million tonnes of finished product or ore; K₂O = potassium oxide, the grade basis; MOP = muriate of potash; net selling price = a mine/plant-gate netback after freight, not the delivered retail price; adjusted EBITDA and adjusted net debt are the company’s non-GAAP measures.)

Figure 1. Nutrien in numbers

Table 1. Nutrien in numbers

Source: Nutrien full-year 2025 results (10 Feb 2026); Nutrien 2025 Annual Information Form ; share price and market capitalisation from stockanalysis.com , 24 Aug 2026. Enterprise value and free cash flow are author-derived from these figures.

How to read this analysis: Here for the verdict? The statcards above and the rating in Section 9 are the whole story. Want the evidence? Read Section 2 (the assets) through Section 7 (the valuation).

The thesis in brief. The bull case is quality and cash: the lowest-cost, longest-life potash reserve base on earth (1,709 Mt, mine lives from 20 to 116 years), a low-cost North American nitrogen book, and a retail network the market arguably under-credits — all throwing off ~$4 billion of operating cash flow and a growing, well-covered dividend. The bear case is that all of this is already in the price: at 7.9× EBITDA the stock is neither cheap nor expensive, the fertilizer cycle can halve potash margins, and a persistent conglomerate discount says the market is not paying up for the retail arm. What tips it is the potash price and the pace of simplification — a sustained move above the mid-cycle netback, or a clean Phosphate exit that lets the market re-rate the core, would move a fairly-valued stock into re-rating territory. See Section 9 for the full rating.

2. Assets & operations

Nutrien sits at the centre of the potash market, which the Potash — A Complete Market Guide covers in full: a concentrated, oligopolistic industry where a handful of Canadian, Russian and Belarusian producers set the price, and where the 2022–2023 disruption to Belarusian and Russian supply reshaped trade flows in Nutrien’s favour. This section spends its words on Nutrien’s own assets rather than re-teaching that market.

2.1 Portfolio overview & map

Nutrien’s value is anchored in six Saskatchewan potash mines, supported by a large but more cyclical nitrogen book, a phosphate business it is trying to exit, and the retail network that generates two-thirds of revenue. The upstream assets are all wholly owned and operated.

Table 2. Nutrien asset portfolio (2025)

Source: Nutrien 2025 Annual Information Form (reserves proven & probable under NI 43-101 for potash / SK-1300 for phosphate, effective 31 December 2025) and the full-year 2025 results . Every upstream asset is publicly listed under NTR (Public, TSX & NYSE: NTR) and wholly owned. Reserve and mine-life figures are estimates on the codes and effective date stated.

Concentration. For a company this large, the value is strikingly concentrated in one commodity and one province: the six Saskatchewan potash mines hold 1,709 Mt of proven and probable reserves and produced 14.0 Mt in 2025 — about 19% of world potash output — from ground Nutrien can mine under leases covering roughly 973,000 acres. Rocanville and Lanigan alone supplied over half of 2025 finished potash. Potash and Nitrogen together generate the great majority of segment EBITDA; Retail generates two-thirds of the revenue but under a fifth of the profit; Phosphate is small and being shopped. A proportional-symbol asset map would show a dense cluster in Saskatchewan and a scatter of nitrogen and retail sites across the US Midwest and South — but that read is carried by the table above and this paragraph, not drawn (Section 10.1).

2.2 Revenue split — by segment & by earnings

Nutrien is not a single-commodity producer, so the “what earns the money?” question splits two ways, and the two answers disagree — which is the whole story of the business. On revenue, Retail dominates because distribution turns over a large, low-margin book of third-party product. On adjusted EBITDA, Potash and Nitrogen dominate, because that is where the low-cost, high-margin tonnes are. Reading the two figures together is the single clearest picture of the company.

Figure 2. Nutrien revenue by segment, 2025 (US$ bn)

Figure 3. Nutrien adjusted EBITDA by segment, 2025 (US$ bn)

Source for Figures 2 and 3: Nutrien full-year 2025 results ; segment revenue shares are author estimates from segment disclosures.

Retail earns roughly 66% of revenue but only ~27% of segment EBITDA; Potash and Nitrogen together earn ~68% of EBITDA on ~27% of revenue. That gap — a high-margin upstream mining core bolted to a large, low-margin distribution business — is exactly what a sum-of-the-parts valuation exists to price (Section 7), and it is why the market’s single group multiple is a blunt instrument.

2.3 Potash — the franchise

Potash is the reason to own Nutrien. The company operates six mines in Saskatchewan with roughly 20.3 Mtpa of nameplate capacity — about 20% of world capacity — and produced 14.0 Mt of finished product in 2025, some 19% of global output and about 57% of North American production. Reserves total 1,709 Mt of proven and probable ore under NI 43-101, at average in-mine grades of roughly 21–24% K₂O, effective 31 December 2025. The mine lives are the standout feature of the whole company: Vanscoy carries a ~116-year reserve life, Allan ~51 years and Cory ~34 years, while the two highest-rate mines, Rocanville (6.5 Mtpa nameplate) and Lanigan (3.8 Mtpa), carry ~20–26 years each. These are effectively multi-generational, permitted, low-cost assets in the world’s premier potash jurisdiction.

Cost position is the other half of the story. Saskatchewan conventional potash sits in the lowest cost quartile globally, and Nutrien’s realised net selling price — a mine-gate netback after freight — was US$252/t in 2025 (US$286/t in North America, US$235/t offshore), up from US$215/t in 2024 as the market firmed. Nutrien deliberately runs its network below nameplate, matching supply to demand rather than flooding the market, and can flex production toward ~18 Mtpa without major capital. All offshore potash is marketed through Canpotex, the 50/50 export joint venture with Mosaic (see Section 4.3), which sells to markets outside North America. The single asset-level risk is price: potash is a cyclical commodity, and a US$25/t move in the net selling price swings group EBITDA by roughly US$280 million (Section 7).

2.4 Nitrogen — the low-cost North American book

Nitrogen is Nutrien’s second EBITDA engine and its most gas-exposed. The segment runs nine ammonia complexes — eight in North America (Georgia, Texas, Alberta, Louisiana, Ohio) plus, until October 2025, one in Trinidad — with roughly 7.3 Mtpa of gross ammonia and 4.6 Mtpa of urea nameplate capacity, about 3% of world capacity. The North American plants enjoy structurally cheap Henry Hub and AECO natural gas, the key feedstock, which is the source of the segment’s margin advantage over European and Asian producers priced off higher gas. In October 2025 Nutrien completed a controlled shutdown of the Trinidad facility because of persistent gas-supply and port-access uncertainty — a portfolio decision that removes a marginal, high-cost, low-free-cash-flow asset and concentrates the segment on its advantaged North American base. Nitrogen delivered $2.15 billion of adjusted EBITDA in 2025 on higher net selling prices and improved production. The asset-level risks are the natural-gas price and, increasingly, carbon compliance costs on ammonia production, one of the more emissions-intensive industrial processes.

2.5 Phosphate & the development pipeline — the piece being sold

Phosphate is the smallest and lowest-return segment, and the one Nutrien is trying to exit. It comprises two US mine-and-processing complexes — Aurora, North Carolina and White Springs, Florida — with 7.4 Mtpa of phosphate-rock capacity; 2025 rock production was 6.05 Mt (4.66 Mt Aurora, 1.39 Mt White Springs). The segment earned about $0.38 billion of adjusted EBITDA in 2025, roughly 6% of the group, and has been under a strategic review since the third quarter of 2025 — a likely divestiture that would further concentrate Nutrien on potash, nitrogen and retail. The development pipeline elsewhere is modest and brownfield: incremental potash debottlenecking, nitrogen efficiency projects (including automation at Redwater and Geismar), and retail proprietary-product and digital rollouts. There is no large greenfield project consuming capital, which is a feature, not a bug, for a mature cash-returning major.

2.6 Retail — the network the market discounts

Nutrien Ag Solutions is the largest agricultural-retail network in North America and a genuine differentiator: more than 1,800 locations, over 4,200 crop consultants, roughly 80 terminals and 50 distribution centres serving farmers directly with crop nutrients, crop protection, seed, services and financing. Retail generated about two-thirds of 2025 revenue and $1.74 billion of adjusted EBITDA, up on lower operating expenses from cost-savings initiatives and stronger proprietary-products margin. Its revenue mix is roughly 42% crop nutrients, 35% crop protection, 12% seed, 5% services, 5% merchandise and 1% financial. The bull argument for Nutrien rests substantially here: a stable, service-led distribution business of this scale would command a higher multiple as a standalone than the blended group multiple the market applies — the source of the conglomerate discount the valuation quantifies (Section 7). The bear counter is that retail earnings track farm economics, input demand and working-capital cycles, and are not as annuity-like as the multiple bulls would like.

2.7 Group production, reserves & costs

At the group level Nutrien is a mature, supply-disciplined producer whose earnings are driven by fertilizer prices rather than by volume growth. Total manufactured fertilizer sales were 27.5 Mt in 2025 (potash, nitrogen and phosphate combined). Group adjusted EBITDA has been intensely cyclical — the figure below is the clearest single picture of the business — swinging from $7.1 billion in 2021 to a record $12.2 billion at the 2022 price peak, then normalising to ~$6 billion as fertilizer prices reverted. The 2025 figure of $6.05 billion sits close to what looks like a mid-cycle level, which matters for the valuation: it means 2025 earnings are neither a trough to be discounted nor a peak to be faded.

Figure 4. Nutrien adjusted EBITDA by year (US$ bn)

Source: Nutrien annual reports and full-year 2025 results . The 2022 peak reflects the post-invasion fertilizer price spike; 2024–2025 approximate a mid-cycle level.

2.8 Peer positioning

Nutrien’s peer set is the small group of large, listed, diversified fertilizer producers — the only companies scored against it anywhere in this analysis: Mosaic (NYSE: MOS) — potash and phosphate, Nutrien’s Canpotex partner; CF Industries (NYSE: CF) — the North American nitrogen pure-play; ICL Group (NYSE: ICL) — potash, phosphate and specialty products from the Dead Sea; and K+S (XETRA: SDF) — the German potash and salt producer. None is currently in a pending acquisition or merger. Nutrien is the largest and most diversified of the set, uniquely paired with a retail network none of the others owns; the trade-off is that this diversification is what produces the conglomerate discount.

Table 3. Peer positioning — quality metrics

Source: company reports; figures approximate and on differing bases (Nutrien reports in USD, K+S in EUR). Peer basis: large listed diversified fertilizer producers. To screen Nutrien against the full fertilizer and mining universe on production, reserves, cost and margin, use Metal Pilot.

Against this set Nutrien is the scale and diversification leader with the best jurisdiction profile and the longest reserve life, but not the highest-margin name — CF’s gas-advantaged nitrogen pure-play runs a structurally higher margin, and Nutrien’s group margin is diluted by the low-margin retail book. That is the gap the scorecard quantifies: Nutrien wins on asset quality, reserves, life and jurisdiction, and gives back some ground on blended margin and on the growth it deliberately forgoes.

3. Financials & balance sheet

Nutrien’s financials tell a clean cyclical story: a record top in 2022, a two-year normalisation, and a 2025 recovery. Revenue rose 3.5% to $26.9 billion in 2025, adjusted EBITDA rose 13% to $6.05 billion, net earnings more than tripled to $2.30 billion ($4.66 diluted EPS), and the company generated ~$4.0 billion of operating cash flow against ~$2.0 billion of capital expenditure — comfortably funding a growing dividend and buybacks. Applying the framework in the Commodity Financials — A Metrics Guide rather than re-teaching it: the income statement is real (margins driven by realised fertilizer prices against low unit costs), the balance sheet survives the down-cycle (investment-grade, 1.8× leverage), and the cash backs the profit (operating cash flow of ~$4.0 billion sits well above $2.30 billion of net earnings, as it should for a heavy-depreciation miner).

Table 4. Five-year financial summary (US$ m unless noted)

Source: Nutrien full-year 2025 results and prior annual reports; free cash flow history (MacroTrends). Revenue, adjusted EBITDA, net earnings, EPS, shares and dividends are as reported; operating cash flow, capital expenditure, free cash flow and net debt for 2021–2024 are on a consistent-basis approximation from the filings and are marked ~ where not taken from the latest release. Free cash flow = operating cash flow − capital expenditure.

Balance sheet & liquidity. Nutrien is investment-grade (rated around BBB / Baa2) with adjusted net debt of $11.06 billion at year-end 2025, or 1.8× adjusted EBITDA — comfortably inside the company’s through-cycle target. The important stress test is the cycle: at a mid-cycle-to-low potash netback the leverage ratio rises toward ~2.2–2.5× (it was 2.2× in the soft 2024 year and 1.9× in 2023), which is elevated but not distressed for a business of this cash-generation and asset quality. Liquidity is strong — ~$0.7 billion of cash plus large committed undrawn facilities — and the debt-maturity ladder is well spread with no single wall in a weak-price year. Reclamation and asset-retirement obligations at the potash and phosphate sites are a genuine long-dated liability (mine decommissioning, phosphogypsum-stack management, land reclamation), carried in provisions and funded through financial-assurance arrangements.

Capex, hedging & capital returns. Capital expenditure has been cut hard — from ~$2.76 billion in 2023 to $2.0 billion in 2025, with 2026 guided at $2.0–2.1 billion — and is overwhelmingly sustaining rather than growth, consistent with a mature, no-large-greenfield major. On treasury policy (the Document Description hedge field), Nutrien is selectively, not systematically, hedged: it uses derivatives to manage natural-gas input costs, interest rates and foreign exchange, but deliberately retains full exposure to crop-nutrient prices for shareholders — so there is no product-price hedge book damping the potash and nitrogen cycle, which is why the scenario analysis in Section 7 flexes the price directly. Capital returns are disciplined and growing: 2025 returned ~$1.06 billion in dividends and $551 million in buybacks (~2% of shares), a 30% increase in total cash returns, with the dividend raised again to $2.20 annualised for 2026 — a record of steady per-share dividend growth (from $1.84 in 2021), covered by free cash flow through the cycle, while the share count has fallen from ~570 million to ~486 million over five years.

4. Management, strategy & corporate structure

4.1 Management & governance

Nutrien is led by President and Chief Executive Officer Ken A. Seitz, appointed in 2022, who previously ran the company’s Potash business as EVP & CEO of Potash — a potash-and-agriculture operator by background, well matched to the simplification-and-cash-flow strategy. The Board is chaired by Russell K. Girling, the former President and CEO of TransCanada Pipelines (now TC Energy), a director since 2018 with deep large-cap infrastructure and capital-allocation experience. The Board has ten members and governs through four standing committees — Audit, Human Resources and Compensation, Corporate Governance and Nominating, and Safety — the last of which reflects the operational, mining-and-chemicals nature of the business. Governance is anchored in a comprehensive Code of Conduct and Anti-Corruption Policy. A CFO transition occurred in the 2024–2025 period; the current finance leadership continues the disciplined capital framework.

4.2 Strategy & capital allocation

The stated strategy is portfolio simplification and structural free-cash-flow growth. Management is focusing the company on its core potash, nitrogen and retail businesses and exiting non-core positions — the Phosphate and Trinidad Nitrogen reviews are the current expression of this. Capital allocation is explicitly prioritised to maintain investment-grade ratings, fund and grow the dividend, and execute buybacks under normal-course issuer bids, in that order, after sustaining capex. The growth agenda is deliberately incremental: brownfield potash tonnes toward ~18 Mtpa of network capability, nitrogen efficiency and automation, and retail-led differentiation through proprietary products and digital agronomy tools to lift Retail margins. There is no transformational M&A ambition in the current frame — the 2018 Agrium–PotashCorp merger that created Nutrien remains the defining structural event, and the strategy since has been to optimise and return cash rather than to build.

4.3 Ownership & corporate structure

Nutrien is a widely held public company (TSX & NYSE: NTR) with no controlling shareholder; the register is institutional. The most material recent structural moves are divestitures executed in 2025: the sale of its 50% equity interest in Profertil S.A. (the Argentine nitrogen JV) for US$595 million, and the full divestiture of its stake in Sinofert Holdings for US$193 million — together ~$0.8 billion realised and a cleaner portfolio. In October 2025 Nutrien completed the controlled shutdown of its Trinidad nitrogen facility over gas-supply and port-access uncertainty. The key ongoing strategic relationship is Canpotex Limited, the 50/50 joint venture with Mosaic that is the exclusive marketing and distribution company for Canadian potash sold outside North America — the channel through which all of Nutrien’s offshore potash flows, accounted for under the equity method. Material operating subsidiaries include Potash Corporation of Saskatchewan Inc., Agrium Canada Partnership and PCS Sales (USA), Inc. There are no material warrants, strategic-investor lock-ups or blocking shareholdings.

5. ESG & sustainability

Nutrien’s sustainability framework is organised around safety, health, environment and security, under the stated vision of “everyone home safe, every day,” with the Board’s dedicated Safety committee providing oversight. The most concrete environmental initiative is carbon capture at the Redwater, Alberta nitrogen facility, which captured and exported approximately 274,000 tonnes of CO₂ in 2025 into the Alberta Carbon Trunk Line — a genuine, measurable reduction in the emissions intensity of ammonia production, the segment’s main ESG exposure. The company integrates climate-risk assessment into operations and monitors compliance with provincial and federal greenhouse-gas trading systems; carbon pricing on nitrogen production is a real and escalating cost, not a footnote. On the social side, an Indigenous Content Playbook in Saskatchewan supports local Indigenous supply-chain participation around the potash operations. Environmentally, the material liabilities are the reclamation and asset-retirement obligations at the potash and phosphate sites — mine decommissioning, land reclamation and, at Phosphate, phosphogypsum-stack management — for which Nutrien maintains financial-assurance funds. The honest read is a solid, above-median but not sector-leading ESG profile: potash mining is relatively low-impact, but nitrogen is emissions-intensive and phosphate carries legacy environmental liabilities, so the net picture is around peer-median on the environmental pillar and stronger on governance and disclosure.

6. Risks

Nutrien’s risks are dominated by one variable — the fertilizer price cycle — with a set of secondary operational, jurisdictional and balance-sheet exposures behind it. The register below is stated before the valuation so the scenario analysis in Section 7 prices it.

Table 5. Risk register

Figure 5. Risk matrix — likelihood × impact

Source: this analysis, from the Nutrien 2025 Annual Information Form risk factors. Positions are a qualitative assessment; the shaded band marks the high-impact region. H/M/L = high/medium/low.

The one risk that would break the thesis is the potash price. Nutrien is not levered enough, nor concentrated in a single mine, to fail on operational grounds; the equity’s return is a function of where the potash netback settles across the cycle, and everything else — the retail multiple, the phosphate exit, carbon costs — moves the answer at the margin. That is exactly why the valuation is built around a potash-price scenario grid.

7. Valuation

Valuation as of 24 August 2026, in US dollars (Nutrien reports in USD; no FX conversion). Horizon: spot fair value. Deck: the model’s swing input is Nutrien’s realised potash net selling price (a mine-gate netback), on a US$50/t grid — base US$250/t (2025 realised ~US$252/t, held on the grid), with the full grid as the scenario set — deep bear $150 / bear $200 / base $250 / bull $300 / deep bull $350; the group EV/EBITDA target of 7.75× is the relative anchor (its own 6.75×–8.75× band is the sensitivity’s second axis). Discount is expressed through the multiple, not a separate rate, because the primary method is a multiple-based sum-of-the-parts.

Nutrien is a diversified major, so the primary method is a sum-of-the-parts (each segment on its own EV/EBITDA convention), cross-checked by a blended group EV/EBITDA and an FCF-yield support price. On these methods the blended base-case fair value is ~US$75.8/share against a US$75.82 price — an implied return of essentially 0%, so the read is Fairly valued (wide band): a high-quality franchise the market has priced correctly, with a wide scenario spread ($49–$109) that is entirely a function of where the potash cycle settles.

7.1 Method selection

Table 6. Valuation method selection

Every weighted method emits a value per share. Input-family exposure: intrinsic (SOTP) 55% single-method; cash-flow (EV/EBITDA + FCF-yield) 45% across two methods — under the 50% collinear cap. Weights are the standard diversified-major set.

7.2 Sum-of-the-parts (the primary value)

The SOTP values each segment’s 2025 adjusted EBITDA on a multiple appropriate to its quality, sums to enterprise value, and bridges to equity — subtracting net debt, minorities and a modest conglomerate discount. The base multiples: Potash 9.0× (best-in-class, lowest-cost, longest-life), Nitrogen 7.5× (gas-advantaged NA book), Retail 9.0× (stable distribution, arguably light versus standalone comparables), Phosphate 5.0× (low-return, being sold), with corporate costs capitalised at 7.5×. A 5% conglomerate discount — smaller than the market appears to apply, because Nutrien’s retail-plus-upstream integration is genuine — completes the bridge.

Figure 6. Sum-of-the-parts NAV build-up (US$ bn)

Figure data: this analysis’ SOTP model on 2025 segment adjusted EBITDA (Potash $2.25 bn × 9.0×, Nitrogen $2.15 bn × 7.5×, Retail $1.74 bn × 9.0×, Phosphate $0.38 bn × 5.0×, corporate −$0.47 bn × 7.5×), less $11.06 bn net debt, $0.70 bn minorities/pension and a 5% conglomerate discount. Equity value $36.7 bn ÷ ~478 m shares = US$76.8/share. Current market cap ~$36.3 bn.

The gross segment enterprise value is ~$50.4 billion; the equity value of $36.7 billion works out to US$76.8/share — essentially the market price, which tells you the market is already valuing Nutrien at close to its honest sum of parts, with only a small residual conglomerate discount. The bull case here is that Retail deserves closer to 10× (adding ~$1.7 billion of EV, ~$3.60/share) and that the discount should be zero.

7.3 Relative valuation & the FCF-yield support

Blended group EV/EBITDA. Nutrien and its diversified-fertilizer peers trade around 7–8× EV/EBITDA; at a 7.75× target on 2025 adjusted EBITDA of $6.046 billion, enterprise value is $46.9 billion, less $11.06 billion net debt and $0.70 billion minorities = $35.1 billion equity, or US$73.5/share. This is a mid-cycle multiple on a mid-cycle EBITDA: 2025 sits close to the group’s own through-cycle average, so no additional normalisation is applied.

FCF-yield support. Nutrien generated ~$2.0 billion of free cash flow in 2025; at a 5.5% sustainable FCF yield — in line with its own history and the diversified-major peer set — the implied equity value is $36.4 billion, or US$76.1/share. This is a cash-flow-multiple method, not an income method, and it carries 20% of the blend.

7.4 Cross-checks

Analyst consensus (0% weight, V12): recent sell-side targets cluster around US$76–80 (e.g. BNP Paribas $80 Outperform, Barclays $78 Overweight, Morgan Stanley $76) — a ~$78 midpoint, ~3% above the current price and within a couple of dollars of this analysis’ blended base fair value. The consensus and the model agree that Nutrien is trading close to fair value.

Market-implied potash netback (0% weight, V19): running the SOTP backwards, the current US$75.82 price implies a potash net selling price of roughly US$250/t in perpetuity — almost exactly the 2025 realised netback of ~US$252/t. In other words, the market is pricing today’s potash margin as the through-cycle norm: it is neither betting on a Belarus-driven recovery nor pricing a return to the 2020 lows. That is a reasonable, unremarkable assumption — which is another way of saying the stock is fairly valued.

7.5 Scenario analysis

Each column is a self-consistent world on the potash-netback grid: the potash price moves the segment’s EBITDA (±$560 m per $50/t), and the target multiples step with sentiment. Every weighted method is recomputed in each.

Table 7. Scenario assumptions and per-method values (US$/share)

Illustrative scenarios, not forecasts. The multiple steps ±0.5× per rung with the deck; because 2025 EBITDA is near mid-cycle, flexing both is justified within V17.

Figure 7. Blended fair value — potash netback × group EV/EBITDA multiple (US$/share)

Figure data: this analysis’ blended fair value (SOTP 55% / EV-EBITDA 25% / FCF-yield 20%). Columns are Nutrien’s realised potash netback on the US$50/t grid; rows are the group EV/EBITDA target replacing the discount rate for this multiple-based method. Base case $250/t at 7.75× (outlined) = $76. A one-rung ($50/t) potash move shifts fair value by roughly ±$10/share (±13%).

7.6 Fair value & conclusion

Table 8. Fair-value blend (US$/share)

Source: this analysis; weights per the diversified-major default. All figures in USD; horizon: spot fair value. Cross-checks at 0% weight: analyst consensus ~$78 (+3%), market-implied potash netback ~$250/t. Total-return line: at ~0% implied price return plus a 2.9% dividend yield, the implied one-year total return is ~+3%.

The blended base-case fair value of US$75.8 against a US$75.82 price gives an implied return of essentially zero → Fairly valued. The scenario range is wide — $48.6 in the deep-bear world to $108.7 in the deep-bull — and because the deep-bear case sits 36% below the current price, the read carries the (wide band) qualifier: the downside if potash reverts toward US$150/t is real, driven almost entirely by the one assumption the whole valuation turns on. Consensus ($78) and the market-implied netback (~$250/t) both corroborate a fairly-valued read.

Assumptions box. Valuation date 24 Aug 2026; balance-sheet date 31 Dec 2025; horizon spot fair value. Currency USD (no FX). Deck: potash net selling price on a US$50/t grid, base $250/t (2025 realised ~$252/t). “Discount rate” is expressed as the group EV/EBITDA target (6.75×–8.75×, base 7.75×), since the primary method is a multiple-based SOTP rather than a DCF. Share count ~478 m diluted. Peer basis: trailing EV/EBITDA, adjusted EBITDA, on the diversified-fertilizer set. Weights: SOTP 55% / EV-EBITDA 25% / FCF-yield 20% (diversified-major default). NAV provenance: author-built SOTP on company-reported segment EBITDA. Primary yardstick: SOTP equity value per share.

8. Near-term catalysts (1–3 years)

Nutrien’s forward positives are incremental and cash-driven rather than transformational — which suits a mature major, but means the catalysts move the verdict at the margin rather than re-rating the stock overnight.

Table 9. Near-term catalysts (1–3 years)

These are the events that would confirm the bull case: a firmer potash netback and a completed Phosphate exit together would take the stock from “priced about right” toward “re-rating candidate.” The swing factor is execution and the potash cycle — neither is within management’s full control, so the catalysts are framed as guidance and possibility, not as forecasts. (No takeover-optionality subsection is included: Nutrien is a diversified major, not an explorer or developer, so an M&A-target read would be speculation the reader cannot act on.)

9. Rating & verdict

Nutrien scores as a Solid (★★★★) company: best-in-class on the assets that matter most and above-median almost everywhere else, with the honest deductions being a blended margin diluted by retail, a deliberately low growth profile, and the emissions intensity of its nitrogen book. The nine dimensions are scored against the same rubric every company in the sector uses, relative to the peer set declared in Section 2.8 (Mosaic, CF Industries, ICL, K+S).

Table 10. Scorecard — Nutrien

Weighted average: 0.75 + 0.60 + 0.75 + 0.60 + 0.60 + 0.19 + 0.25 + 0.31 + 0.19 = 4.24/5 → ★★★★ (Solid). Dominant dimensions (asset quality, cost, reserves, balance sheet, capital allocation) carry 15% each; the rest 6.25%. Sources as cited in Sections 2–5.

The two-axis verdict. Composite quality ★★★★ (Solid, 4.2/5); value read Fairly valued (wide band) as of 24 August 2026; verdict: Priced about right — the edge is a catalyst, not the price. Nutrien is a genuinely high-quality franchise that the market has valued correctly; the return from here depends on the potash cycle and on management finishing its simplification, not on a discount closing.

The bull case is quality, longevity and cash: the best potash reserve base in the world, a low-cost nitrogen book, an under-credited retail network, and ~$4 billion of operating cash flow funding a growing dividend and shrinking share count — with a completed Phosphate exit and a firmer potash netback as the levers that would push the sum-of-the-parts into the open. The bear case is that all of this is already in a 7.9× multiple, that potash is cyclical enough to take fair value 36% lower in a reversion, and that the conglomerate discount has proved durable because retail earnings are less annuity-like than bulls claim.

The specific thing that tips it is the potash netback together with the Phosphate review. A sustained move above the ~$250/t through-cycle netback the market is pricing, or a clean Phosphate divestiture that lets the core re-rate toward its parts, turns a fairly-valued high-quality compounder into a re-rating candidate. Absent either, Nutrien is exactly what its multiple says: a best-in-class fertilizer major to own for the compounding and the dividend, bought on cyclical weakness rather than at fair value.

To rank Nutrien against every listed fertilizer and mining name on the same nine dimensions — reserves, cost, reserve life, margin and value — screen the sector on Metal Pilot.

10. Sources, methodology & disclaimer

10.1 Sources, methodology & data vintage

Company filings. Nutrien 2025 Annual Information Form (year ended 31 December 2025) — the spine of this analysis: the six potash mines and their reserves (proven & probable under NI 43-101, effective 31 December 2025), the nitrogen and phosphate assets, the Trinidad shutdown, the Profertil and Sinofert divestitures, the Canpotex relationship, leadership, committees and sustainability disclosures. Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance (10 February 2026) — 2025 revenue, segment and group adjusted EBITDA, net earnings, EPS, cash flow, net debt, dividend, buyback and 2026 guidance.

Exchange and market data. stockanalysis.com for the share price ($75.82), market capitalisation (~$36.3 bn), share count, trailing EPS ($4.93) and 52-week range, as of the NYSE close on 24 August 2026; the free-cash-flow history (MacroTrends) and prior Nutrien annual reports for the five-year figures. Analyst targets (BNP Paribas, Barclays, Morgan Stanley) from published broker notes in mid-2026.

Commodity context. Potash (MOP) pricing from FertilizerPrice.com and market reporting (US Corn Belt granular MOP ~$310–380/t in 2026; Nutrien’s realised netback ~$252/t in 2025); the long-run potash market in the Potash — A Complete Market Guide . The valuation framework follows the Commodity Stock Valuation — A Valuation Guide and the financial-statement review the Commodity Financials — A Metrics Guide .

Methodology. Durable structure (reserves, mine life, capacity, ownership, jurisdiction) is kept separate from the dated market layer (share price, market cap, enterprise value, multiples, valuation) throughout. The data-as-of date is 24 August 2026; market data is as of the NYSE close that day; reserves and production are effective 31 December 2025; segment and financial figures are FY2025. Nutrien reports on a calendar fiscal year in US dollars under IFRS. Scorecard weights follow the diversified-major reference case (dominant dimensions 15%, others 6.25%), sum to 100%, with no dimension not-applicable. The valuation is a multiple-based sum-of-the-parts reproducible from Figure 6, Table 8 and the assumptions box; the segment multiples, conglomerate discount, corporate-cost charge, potash-EBITDA sensitivity and free-cash-flow estimate are author assumptions, not company figures. Two figures from the standard set are not drawn: the asset map (a proportional-symbol map of the Saskatchewan, US and Australian footprint — the Section 2.1 portfolio table and concentration paragraph carry that read instead), and a per-mine production time-series (the group EBITDA history in Figure 4 carries the cyclical read, with per-mine output in Table 2). Some 2021–2024 cash-flow and net-debt figures in Table 4 are consistent-basis approximations rather than latest-release figures, marked ~. Update cadence: refreshed on each annual report and on material events — the next natural refresh is the Q3/Q4 2026 results and any outcome of the Phosphate strategic review.

Provenance: Nutrien Ltd. — Annual Information Form — 2025.

10.2 Disclaimer & disclosure

This analysis is for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. It is a point-in-time snapshot as of 24 August 2026: the share price, market capitalisation, enterprise value, multiples and valuation read all move, and fertilizer equities are cyclical and volatile. Reserve, production, segment and forecast figures are estimates, prepared on the codes and bases stated beside each table, and scenario economics are not achieved results. The Quality × Value verdict is an analytical read, never an instruction to the reader. This report was prepared with AI assistance; figures were sourced from primary filings and reviewed, but readers should verify every number against the original documents before acting on it. The author holds no position in Nutrien Ltd. or in any company named here. Please do your own research and consult a licensed financial adviser.